Catasys Inc. (NASDAQ:CATS) released its earnings results on Tuesday. The company reported ($0.19) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.15) by ($0.04), reports.
Catasys (CATS) opened at $3.64 on Wednesday. Catasys has a 12 month low of $3.34 and a 12 month high of $14.00.
TRADEMARK VIOLATION NOTICE: This piece was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The legal version of this piece can be viewed at https://stocknewstimes.com/2017/11/15/catasys-inc-cats-issues-earnings-results-misses-estimates-by-0-04-eps.html.
A number of research firms recently commented on CATS. Telsey Advisory Group began coverage on Catasys in a research note on Wednesday, October 18th. They issued a “buy” rating on the stock. Zacks Investment Research raised Catasys from a “sell” rating to a “hold” rating in a research note on Monday, August 7th. Taglich Brothers began coverage on Catasys in a research note on Wednesday, October 18th. They issued a “speculative buy” rating and a $8.00 target price on the stock. Finally, ValuEngine cut Catasys from a “hold” rating to a “sell” rating in a research note on Saturday, October 21st.
Catasys Company Profile
Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The companys OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.
Receive News & Ratings for Catasys Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys Inc. and related companies with MarketBeat.com's FREE daily email newsletter.